ARCELLX INC

About

Arcellx Inc. is a clinical-stage biotechnology company focused on the development of innovative cell therapies for the treatment of patients with cancer and other incurable diseases. The company utilizes its proprietary SparX platform to engineer T-cell therapies designed to target specific antigens with high precision and safety. Its lead product candidate is currently being evaluated in clinical trials for patients with relapsed or refractory multiple myeloma.